Sonoma Biotherapeutics, Inc.
Clinical trials sponsored by Sonoma Biotherapeutics, Inc., explained in plain language.
-
New RA drug SBT777101 enters first human safety trial
Disease control Recruiting nowThis study tests a new drug called SBT777101 in 24 adults with moderate-to-severe rheumatoid arthritis (RA) who have not responded well to other treatments. It is the first time this drug is given to humans, so the main goal is to check its safety and side effects at different do…
Phase: PHASE1 • Sponsor: Sonoma Biotherapeutics, Inc. • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Gene therapy Follow-Up: are delayed side effects hiding?
Knowledge-focused Recruiting nowThis study watches people who already got a gene-modified Treg treatment for rheumatoid arthritis or hidradenitis suppurativa. Researchers want to see if any delayed side effects show up over time. About 36 participants will be followed to track safety and how long the modified c…
Sponsor: Sonoma Biotherapeutics, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 04:34 UTC